Welcome to the tag category page for Blood Sugar Levels!
Empagliflozin is an antidiabetic medication used to treat type 2 diabetes by lowering blood sugar levels. It belongs to the class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors, and works by preventing the absorption of glucose in the kidneys. Empagliflozin is sold under the brand name Jardiance and is taken orally. It is not recommended for use in type 1 diabetes. Empagliflozin can cause side effects such as increased urination, dehydration, and low blood pressure. However, it has been found to be superior to metformin in improving arterial stiffness parameters. Patients taking empagliflozin should follow a proper diet and exercise program to control their blood sugar levels.
Ozempic is a drug used to treat type 2 diabetes by improving blood sugar levels in adults. It is a once-weekly injection of semaglutide that stimulates insulin secretion in a glucose-dependent manner. The dosage for Ozempic is gradually increased over four weeks. It may also be used for weight loss as it suppresses appetite. However, taking Ozempic may cause kidney problems, and doctors may monitor kidney health during treatment. It is not the same as metformin, another diabetes medication that works differently in the body. Ozempic has gained attention due to its effectiveness and popularity among celebrities and social media influencers.
SGLT, or sodium-glucose transport proteins, are a family of glucose transporters found in the intestinal mucosa and renal proximal convoluted tubules. SGLT2 inhibitors are a class of medication used to treat type 2 diabetes by blocking the reabsorption of glucose in the kidneys and promoting its excretion in the urine. Common examples of SGLT2 inhibitors include Invokana, Farxiga, Jardiance, and Steglatro. SGLT1 is responsible for glucose absorption in the small intestine and reabsorbing about 3% of the filtered glucose load in the renal proximal tubule segment 3. SGLT2, on the other hand, is responsible for the majority of glucose reuptake in the tubular system of the kidney. SGLT2 inhibitors are versatile medications with glycemic and nonglycemic benefits that help lower blood sugar levels in adults with type 2 diabetes.
